Drug-Induced Erythroderma: Causative Medications and Management

Causative Medications

• Other aromatic anticonvulsants can trigger erythroderma through similar mechanisms, as reported by the British Journal of Dermatology 1
• Thiol drugs, phenol drugs, and other agents can trigger pemphigus-like blistering erythroderma, according to the British Journal of Dermatology 2

Clinical Recognition and Management Approach

• The latency between drug initiation and erythroderma onset can range from days to several months, as noted by the British Journal of Dermatology 2
• A thorough drug history covering the previous 2 months, including over-the-counter medications and complementary therapies, is essential, as recommended by Praxis Medical Insights 3
• Stop all suspected medications immediately upon recognition, as this is the cornerstone of management and directly impacts prognosis, according to Praxis Medical Insights 3
• Document the exact dates when treatments were started and when first symptoms appeared, as suggested by Praxis Medical Insights 3

Important Clinical Caveats

• Patients with carbamazepine-induced reactions may cross-react with other aromatic anticonvulsants, as reported by the British Journal of Dermatology 1
• NSAIDs within the same class may show cross-reactivity, particularly in severe reactions, according to the Journal of Allergy and Clinical Immunology and Praxis Medical Insights 4, 5
• Rechallenge with the offending drug can lead to serious and possibly fatal reactions, as warned by Praxis Medical Insights 5